Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James A. Geraghty files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kathleen Goin - $5.09M in PVLA purchases and sales in the last 12 months
- George M. Jenkins - $4.72M in PVLA purchases and sales in the last 12 months
- Kevin Tang - $1.49M in FULC purchases and sales in the last 12 months
- Robert J. Gould - $507K in FULC purchases and sales in the last 12 months
- Elaine J. Heron - $300K in PVLA purchases and sales in the last 12 months
- Alfred Sandrock - $184K in VYGR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James A. Geraghty?
James A. Geraghty is a corporate insider of Fulcrum Therapeutics, Inc. (FULC). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James A. Geraghty last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 6 filings going back to 2024.
Has James A. Geraghty been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1) and 0 open-market sales across all tracked filings.
